Abstract

BackgroundAnti-TNF agents are currently recommended for the treatment of NSAID-resistant ankylosing spondylitis, but limited data are available on their efficacy in axial spondyloarthritis (axSpA), particularly non-radiographic axSpA (nr-axSpA).ObjectivesTo compare the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
SAT0372 Clinical and Imaging Efficacy of Etanercept in Early Non-Radiographic Axial Spondyloarthritis: 48-Week Treatment Data
R Bonin ... J Sieper
Annals of the Rheumatic Diseases | VOL. 73
R Bonin, et. al.R Bonin ... J Sieper
01 Jun 2014
SAT0350 Quality of Life with Etanercept in Early Non-Radiographic Axial Spondyloarthritis: 24 and 48-Week Data from A Randomized, Double-Blind, Placebo-Controlled Trial
J Sieper ... J Bukowski
Annals of the Rheumatic Diseases | VOL. 73
J Sieper, et. al.J Sieper ... J Bukowski
01 Jun 2014
THU0209 Responder vs Non-Responder Baseline Characteristics and Early Response in Patients with Non-Radiographic Axial Spondyloarthritis
J Sieper ... H Jones
Annals of the Rheumatic Diseases | VOL. 74
J Sieper, et. al.J Sieper ... H Jones
01 Jun 2015
THU0207 Comparative Analysis of the Effectiveness of anti-TNF Therapies in Non-Radiographic Axial Spondyloarthritis Using Novel Statistical Techniques
A Benedict ... R Hughes
Annals of the Rheumatic Diseases | VOL. 74
A Benedict, et. al.A Benedict ... R Hughes
01 Jun 2015
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers